1. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328:553-559.
2. Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR. Long-term follow up of patients with
benign thyroid fine-needle aspiration cytologic diagnoses. Surgery. 1989;106:980-986.
3. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med.
1993;118:282-289.
4. Ross D. Thyroid hormone suppressive therapy of sporadic nontoxic goiter. Thyroid. 1992;2:263-269.
5. Cooper DS. Thyroxine suppression therapy for benign nodular disease. J Clin Endocrinol Metab.
1995;80:331-334.
6. Huysmans DAKC, Hermus Ad RMM, Constens FHM, Barentsz JO, Klopperborg PWC. Large,
compressive goiters treated with radioiodine. Ann Intern Med. 1994;121:757-762.
7. Dulgeroff AJ, Hershman JM. Medical therapy for differentiated thyroid carcinoma. Endocr Rev.
1994;15:500-515.
8. DeGroot LJ, Kaplan EL, McMormick M, Strauss FH. Natural history, treatment and course of papillary
thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-424.
9. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am. 1990;19:545-576.
10. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and
follicular thyroid cancer. Am J Med. 1994;97:418-428.
11. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow up report of the impact of
therapy in 576 patients. Am J Med. 1981;70:511-518.
12. Wartofsky L. Use of sensitive TSH assay to determine thyroid hormone therapy, avoid osteoporosis.
Annu Rev Med. 1991;42:341-345.
13. Biondi B, Fazio S, Carella C, et al. Cardiac effects of long-term thyrotropin suppression with
levothyroxine. J Clin Endocrinol Metab. 1993;77:334-338.
14. Barsano CP, Skosey C, DeGroot LJ, Refetoff S. Serum thyroglobulin in the management of patients
with thyroid cancer. Arch Intern Med. 1982;142:763-767.
15. Ozata M, Suzuki S, Miyamoto T, Liu TR, Fierro-Renoy F, DeGroot LJ. Serum thyroglobulin in the
follow up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab. 1994;79:98-105.
16. Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: impact of
therapy in 214 patients. J Nucl Med. 1980;21:733-737.
17. Simpson WJ, Panzarella T, Caruthers JS, Gospodarowicz MK, Sutcliffe SB. Papillary and follicular
thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys. 1988;14:1063-1075.
18. Moley JF. Medullary thyroid cancer. Surg Clin North Am. 1995;75:405-420.
19. Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG, Gagel RF. Applications of genetic
screening information to the management of medullary thyroid carcinoma and multiple endocrine
neoplasia type 2. Endocrinol Metab Clin North Am. 1996;25:1-25.
20. Nel CJC, van Heerden JA, Goellner JR, et al. Anaplastic carcinoma of the thyroid: a clinicopathologic
study of 82 cases. Mayo Clin Proc. 1985;60:51-58.
21. Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphoma:
diagnosis and treatment based on our experience of 119 cases. Thyroid. 1993;3:93-98.
